|
[1] Gupta R, Meghrajani V, Desai R, et al.Primary Malignant Cardiac Tumors: A Rare Disease With an Adventurous Journey[J]. J Am Heart Assoc, 2020, 9(10): e016032. [2] Travis W D, Brambilla E, Nicholson A G, et al.The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260. [3] Moeri-Schimmel R, Pras E, Desar I, et al.Primary sarcoma of the heart: case report and literature review[J]. J Cardiothorac Surg, 2020, 15(1): 104. [4] Chen T W, Loong H H, Srikanthan A, et al.Primary cardiac sarcomas: A multi-national retrospective review[J]. Cancer Med, 2019, 8(1): 104-110. [5] Badge V S, Kohale M, Patil A, et al.Spindle-cell sarcoma of the heart: A case report of a rare cause of cardiac mass[J]. Ann Card Anaesth, 2022, 25(2): 220-224. [6] Neuville A, Collin F, Bruneval P, et al.Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas[J]. Am J Surg Pathol, 2014, 38(4): 461-469. [7] Van Dievel J, Sciot R, Delcroix M, et al.Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy[J]. Oncol Res Treat, 2017, 40(6): 353-359. [8] Bode-Lesniewska B, Zhao J, Speel E J, et al.Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery[J]. Virchows Arch, 2001, 438(1): 57-65. [9] Koyama T, Shimizu T, Kojima Y, et al.Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study[J]. Cancer Discov, 2023, 13(8): 1814-1825. [10] Koelsche C, Benhamida J K, Kommoss F K F, et al. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature[J]. Mod Pathol, 2021, 34(12): 2122-2129. [11] Ito Y, Maeda D, Yoshida M, et al.Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing[J]. Virchows Arch, 2017, 471(3): 423-428.
|